Salmeterol - fluticasone propionate inhalation therapy in the clinical observation of severe COPD_0.docVIP

 PAGE \* MERGEFORMAT 15 Salmeterol / fluticasone propionate inhalation therapy in the clinical observation of severe COPD [Abstract] Objective To study inhaled glucocorticosteroids (ICS) and long-acting β2 agonists (LABA premixed formulations of salmeterol / fluticasone propionate (SAL / FP) of moderate to severe chronic obstructive pulmonary disease (COPD ) treatment. Methods 70 cases of COPD patients (all patients before enrollment did not use any formulation of the hormone, receptor agonists, anticholinergic drugs, no history of oxygen therapy, were randomly divided into two groups,